SLNO: Soleno Therapeutics, Inc. Common Stock Company Profile & Statistics

Soleno Therapeutics, Inc. Common Stock Profile

About

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Info & Links

CEO

Anish Bhatnagar

Headquarters

100 MARINE PARKWAY, SUITE 400
REDWOOD CITY, CA 94065, UNITED STATES

Auditor

Marcum LLP

Share holders

Employees

Soleno Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

2.54B

Enterprise Value

2.34B

Enterprise Value/EBITDA(ttm)

-26.86

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

5.07

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

49.04%

Operating Margin(ttm)

Profit Margin(ttm)

6.25%

Return on Equity(ttm)

-25.88%

Return on Invested Capital(ttm)

-31.35%

Return on Assets(ttm)

-19.84%

Income Statement

Revenue(ttm)

98.67M

Revenue Per Share(ttm)

1.84

Gross Profit(ttm)

96.84M

EBITDA(ttm)³

-87.24M

Net Income Available to Common(ttm)

-78.45M

Diluted EPS(ttm)

-1.84

Share Statistics

Beta (5Y Monthly)

-2.92

52-Week Change

-9.02%

S&P 500 52-Week Change

12.25%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

53.71M

Dividend Yield

0.00%

Float⁴

50.27M

% Held by Insiders

6.40%

% Held by Institutions

97.42%

Balance Sheet

Total Cash(mrq)

498.93M

Total Cash Per Share(mrq)

9.29

Total Debt(mrq)

49.85M

Total Debt/Equity(mrq)

10.08%

Current Ratio(mrq)

16.08%

Quick Ratio(mrq)

15.88%

Book Value Per Share(mrq)

9.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-1.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SLNO

Soleno Therapeutics, Inc. Common Stock